HAE Haemonetics Corp: יחס שווי שוק לערך בספרים

Haemonetics Corporation (HAE) dominates the blood collection sector by creating an ecosystem of specialized software and equipment, which guarantees consistent sales of consumables. This price chart confirms the resilience of this defensive asset, whose revenues are independent of market cycles and amount to 6.43. However, logistic complexities and the slow return of donors to US centers are weighing on growth rates.

To objectively assess the operational success of Haemonetics Corporation (HAE), investors must compare the business's market value with its actual net assets. By analyzing the historical price-to-book ratio, one can determine the extent to which the current share price is justified by the value of the equipment and logistical infrastructure that ensure high profitability in the supply of consumables to medical centers.